These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29034173)

  • 21. Mycobacterium bovis discitis as a complication of intravesical Bacillus Calmette-Guérin therapy.
    Colebatch AN; Mounce KE
    J Clin Rheumatol; 2010 Mar; 16(2):74-5. PubMed ID: 20130477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lumbosacral Vertebral Osteomyelitis With Iliopsoas and Epidural Abscess Following Intravesical Bacillus Calmette-Guérin Therapy.
    Abbas AM; Bhandari J; Ngan A; Shahsavarani S; Verma RB
    Cureus; 2023 Oct; 15(10):e47421. PubMed ID: 38021898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The persistence of bacille Calmette-Guérin in the bladder after intravesical treatment for bladder cancer.
    Bowyer L; Hall RR; Reading J; Marsh MM
    Br J Urol; 1995 Feb; 75(2):188-92. PubMed ID: 7850324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sepsis and multiple organ failure after BCG-instillation for bladder cancer].
    Elmer A; Bermes U; Drath L; Büscher E; Viertel A
    Internist (Berl); 2004 Aug; 45(8):935-9. PubMed ID: 15138643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guérin for bladder cancer.
    Guerra CE; Betts RF; O'Keefe RJ; Shilling JW
    Clin Infect Dis; 1998 Sep; 27(3):639-40. PubMed ID: 9770167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disseminated Mycobacterium bovis infection post-kidney transplant following remote intravesical BCG therapy for bladder cancer.
    Ziegler J; Ho J; Gibson IW; Nayak JG; Stein M; Walkty A; Orr P
    Transpl Infect Dis; 2018 Oct; 20(5):e12931. PubMed ID: 29809299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic Bacillus Calmette-Guerin Infection One Year After Intravesical Immunotherapy Mimicking Sarcoidosis.
    Kc Y; Gupta M; Reid GE; Arif A; Adams E
    Cureus; 2022 Nov; 14(11):e31697. PubMed ID: 36561593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer.
    Lukacs S; Tschobotko B; Szabo NA; Symes A
    Case Rep Urol; 2013; 2013():821526. PubMed ID: 23844314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin immunotherapy.
    Hoag N; Pommerville PJ; Kibsey PC; Cavers DJ; Eddy RJ
    Can J Urol; 2009 Apr; 16(2):4589-91. PubMed ID: 19364433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abdominal aortic aneurysmal and endovascular device infection with iliopsoas abscess caused by Mycobacterium bovis as a complication of intravesical bacillus Calmette-Guérin therapy.
    Mizoguchi H; Iida O; Dohi T; Tomoda K; Kimura H; Inoue K; Iwata T; Tei K; Miura T
    Ann Vasc Surg; 2013 Nov; 27(8):1186.e1-5. PubMed ID: 23972639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma.
    Nadasy KA; Patel RS; Emmett M; Murillo RA; Tribble MA; Black RD; Sutker WL
    South Med J; 2008 Jan; 101(1):91-5. PubMed ID: 18176300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ruptured aortic aneurysm due to Mycobacterium bovis BCG with a delayed bacteriological diagnosis due to false negative result of the MPB 64 immunochromatographic assay.
    Simar J; Belkhir L; Tombal B; André E
    BMC Res Notes; 2017 Jan; 10(1):64. PubMed ID: 28126017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical BCG use.
    Abu-Nader R; Terrell CL
    Mayo Clin Proc; 2002 Apr; 77(4):393-7. PubMed ID: 11936937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder.
    Elzein F; Albogami N; Saad M; El Tayeb N; Alghamdi A; Elyamany G
    Clin Med Insights Case Rep; 2016; 9():71-3. PubMed ID: 27559301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity.
    Lam JS; Benson MC; O'Donnell MA; Sawczuk A; Gavazzi A; Wechsler MH; Sawczuk IS
    Urol Oncol; 2003; 21(5):354-60. PubMed ID: 14670544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
    Pommier JD; Ben Lasfar N; Van Grunderbeeck N; Burdet C; Laouénan C; Rioux C; Pierre-Audigier C; Meybeck A; Choudat L; Benchikh A; Nguyen S; Bouvet E; Yeni P; Yazdanpanah Y; Joly V
    Infect Dis (Lond); 2015; 47(10):725-31. PubMed ID: 26077036
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Meyer RK; Williams SJ; Lee TY
    J Clin Tuberc Other Mycobact Dis; 2020 May; 19():100152. PubMed ID: 32140570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Disseminated BCG infection in patients with urinary bladder carcinoma].
    Korać M; Milosević B; Lavadinović L; Janjić A; Brmbolić B
    Med Pregl; 2009; 62(11-12):592-5. PubMed ID: 20491388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.
    Zlotta AR; Drowart A; Van Vooren JP; de Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K
    J Urol; 1997 Feb; 157(2):492-8. PubMed ID: 8996341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infected Aortic Aneurysm caused by Mycobacterium bovis after Intravesical Bacillus Calmette-Guérin Treatment for Bladder Cancer.
    Nam EY; Na SH; Kim SY; Yoon D; Kim CJ; Park KU; Min SK; Lee SE; Choe PG
    Infect Chemother; 2015 Dec; 47(4):256-60. PubMed ID: 26788410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.